KRAS and carcinoma: In the context of colorectal cancer, mutations in key tumor suppressor genes (APC, TP53, SMAD4) and oncogenes (KRAS, BRAF) are frequently observed, and their acquisition often follows a characteristic sequence during the progression from normal epithelium to adenoma to carcinoma (the “adenoma–carcinoma sequence”) [122,123].